Logo image of SERI.MI

SERI INDUSTRIAL SPA (SERI.MI) Stock Fundamental Analysis

BIT:SERI - Euronext Milan - IT0005283640 - Common Stock - Currency: EUR

2.215  +0.08 (+3.99%)

Fundamental Rating

3

Taking everything into account, SERI scores 3 out of 10 in our fundamental rating. SERI was compared to 61 industry peers in the Chemicals industry. SERI has a bad profitability rating. Also its financial health evaluation is rather negative. SERI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SERI has reported negative net income.
SERI had a positive operating cash flow in the past year.
In the past 5 years SERI reported 4 times negative net income.
Of the past 5 years SERI 4 years had a positive operating cash flow.
SERI.MI Yearly Net Income VS EBIT VS OCF VS FCFSERI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

SERI has a Return On Assets (-2.46%) which is in line with its industry peers.
With a Return On Equity value of -8.71%, SERI is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.46%
ROE -8.71%
ROIC N/A
ROA(3y)-1.44%
ROA(5y)-1.02%
ROE(3y)-4.5%
ROE(5y)-3.16%
ROIC(3y)N/A
ROIC(5y)N/A
SERI.MI Yearly ROA, ROE, ROICSERI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

SERI's Gross Margin of 50.22% is fine compared to the rest of the industry. SERI outperforms 79.37% of its industry peers.
SERI's Gross Margin has improved in the last couple of years.
SERI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.34%
SERI.MI Yearly Profit, Operating, Gross MarginsSERI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

3

2. Health

2.1 Basic Checks

SERI does not have a ROIC to compare to the WACC, probably because it is not profitable.
SERI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SERI has been increased compared to 5 years ago.
The debt/assets ratio for SERI has been reduced compared to a year ago.
SERI.MI Yearly Shares OutstandingSERI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
SERI.MI Yearly Total Debt VS Total AssetsSERI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

SERI has an Altman-Z score of 0.67. This is a bad value and indicates that SERI is not financially healthy and even has some risk of bankruptcy.
SERI has a worse Altman-Z score (0.67) than 76.19% of its industry peers.
SERI has a debt to FCF ratio of 2.53. This is a good value and a sign of high solvency as SERI would need 2.53 years to pay back of all of its debts.
SERI has a Debt to FCF ratio of 2.53. This is amongst the best in the industry. SERI outperforms 92.06% of its industry peers.
SERI has a Debt/Equity ratio of 0.58. This is a neutral value indicating SERI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.58, SERI is not doing good in the industry: 63.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.53
Altman-Z 0.67
ROIC/WACCN/A
WACC7.63%
SERI.MI Yearly LT Debt VS Equity VS FCFSERI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

2.3 Liquidity

A Current Ratio of 1.39 indicates that SERI should not have too much problems paying its short term obligations.
The Current ratio of SERI (1.39) is worse than 63.49% of its industry peers.
SERI has a Quick Ratio of 1.39. This is a bad value and indicates that SERI is not financially healthy enough and could expect problems in meeting its short term obligations.
SERI's Quick ratio of 0.85 is on the low side compared to the rest of the industry. SERI is outperformed by 73.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.85
SERI.MI Yearly Current Assets VS Current LiabilitesSERI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

SERI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.22%, which is quite impressive.
Looking at the last year, SERI shows a very negative growth in Revenue. The Revenue has decreased by -38.31% in the last year.
The Revenue has been growing slightly by 7.16% on average over the past years.
EPS 1Y (TTM)29.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
Revenue 1Y (TTM)-38.31%
Revenue growth 3Y9.82%
Revenue growth 5Y7.16%
Sales Q2Q%-9.79%

3.2 Future

The Earnings Per Share is expected to grow by 18.89% on average over the next years. This is quite good.
Based on estimates for the next years, SERI will show a very strong growth in Revenue. The Revenue will grow by 36.04% on average per year.
EPS Next Y-89.36%
EPS Next 2Y-14.18%
EPS Next 3Y18.89%
EPS Next 5YN/A
Revenue Next Year5.44%
Revenue Next 2Y22.95%
Revenue Next 3Y36.04%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SERI.MI Yearly Revenue VS EstimatesSERI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
SERI.MI Yearly EPS VS EstimatesSERI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SERI. In the last year negative earnings were reported.
Also next year SERI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SERI.MI Price Earnings VS Forward Price EarningsSERI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SERI is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SERI indicates a rather cheap valuation: SERI is cheaper than 98.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.48
EV/EBITDA 9.07
SERI.MI Per share dataSERI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

SERI's earnings are expected to grow with 18.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.18%
EPS Next 3Y18.89%

More info and screens

0

5. Dividend

5.1 Amount

SERI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SERI INDUSTRIAL SPA

BIT:SERI (3/7/2025, 7:00:00 PM)

2.215

+0.08 (+3.99%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.71%
Inst Owner ChangeN/A
Ins Owners56.47%
Ins Owner ChangeN/A
Market Cap119.57M
Analysts80
Price Target5.41 (144.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-502.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF 2.48
P/OCF 1.39
P/B 0.96
P/tB 3.48
EV/EBITDA 9.07
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)0.89
FCFY40.38%
OCF(TTM)1.59
OCFY71.92%
SpS2.93
BVpS2.3
TBVpS0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.46%
ROE -8.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.22%
FCFM 30.56%
ROA(3y)-1.44%
ROA(5y)-1.02%
ROE(3y)-4.5%
ROE(5y)-3.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.34%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.53
Debt/EBITDA 3.57
Cap/Depr 130.41%
Cap/Sales 23.87%
Interest Coverage N/A
Cash Conversion 425.53%
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.85
Altman-Z 0.67
F-Score6
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)99.27%
Cap/Depr(5y)161.41%
Cap/Sales(3y)13.79%
Cap/Sales(5y)17.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
EPS Next Y-89.36%
EPS Next 2Y-14.18%
EPS Next 3Y18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.31%
Revenue growth 3Y9.82%
Revenue growth 5Y7.16%
Sales Q2Q%-9.79%
Revenue Next Year5.44%
Revenue Next 2Y22.95%
Revenue Next 3Y36.04%
Revenue Next 5YN/A
EBIT growth 1Y21.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.61%
EBIT Next 3Y150.95%
EBIT Next 5Y56.38%
FCF growth 1Y303.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1380.45%
OCF growth 3Y357.92%
OCF growth 5Y56.2%